Observed Signal · Nov 5, 2026 · earnings · Source: SEC API · Impact: 3.8/5
Cardlytics Furnishes Q3 2026 Financial Results and Corporate Highlights via Press Release
On November 5, 2026, Cardlytics, Inc. filed a Current Report on Form 8-K under Item 2.02 to announce its financial results for the three and nine months ended September 30, 2026. The announcement was accompanied by a press release furnished as Exhibit 99.1, detailing quarterly financial performance, corporate highlights, and details regarding an investor conference call. In accordance with standard Item 2.02 disclosure rules, the report serves as a furnished announcement rather than a direct filing of detailed financial statements within the 8-K body itself.
Item 2.02 earnings release notices represent standard quarterly disclosures indicating the availability of financial performance updates, though detailed figures reside in the furnished exhibit rather than the 8-K body.
MARKET SIGNALS
Track Cardlytics Signals & Strategic Shifts
Polaris7 connects regulatory filings, primary sources, leadership changes, and M&A activity into structured intelligence. Set up your Polaris7 workspace to monitor relevant companies in your executive briefing.
- Verified primary sources
- Automated briefings
- Instant watchlist setup
Key Takeaways & Evidence Grounding
- Furnished Q3 2026 financial results for the period ended September 30, 2026 under Item 2.02.
- Reported concurrent corporate highlights and held an investor conference call on November 5, 2026.
- Form 8-K includes Exhibit 99.1 (earnings press release) and Exhibit 104 (Inline XBRL cover page).
- Q3 2026 consolidated revenue dropped 30% year-over-year to $32.9 million, with billings decreasing 32% to $57.2 million.
- Net loss for Q3 2026 narrowed to $8.9 million versus $72.7 million in Q3 2025, which included a $58.8 million goodwill and asset impairment charge.
- Monthly Qualified Users (MQUs) fell by 43.7 million to 186.6 million due to the exit of a key U.S. financial institution partner.
- A 1-for-10 reverse stock split was completed on June 5, 2026, and the Bridg divestiture yielded a $13.9 million gain earlier in 2026, though related litigation settlement outlays reached $6.4 million in Q3.
Connected Companies & Entities
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Cardlytics Cuts 15% of Workforce to Achieve $12.2M Annualized Cost Savings
On November 16, 2026, Cardlytics announced a restructuring plan to reduce its workforce by approximately 30 full-time employees, representing about 15% of its total workforce. The plan forms part of a broader cost-reduction initiative aimed at optimizing the company's cost structure, which includes non-headcount measures. Cardlytics projects that these combined efforts will lower operating expenses by approximately $12.2 million on an annualized basis. The company expects to record approximately $0.7 million in non-recurring pre-tax restructuring charges for severance and related expenses, primarily during the fourth quarter of 2026. The restructuring and associated cash outlays are slated for substantial completion by December 31, 2026.
8-K Financial Filing Analysis for Cardlytics (2026-09-11)
On September 4, 2026, Cardlytics, Inc. entered into a settlement and release agreement with Amit Jain, the founder and former CEO of Bridg, Inc., resolving litigation filed in the Delaware Court of Chancery concerning indemnification obligations assumed during Cardlytics' 2021 acquisition of Bridg. Under the agreement, Cardlytics will pay an aggregate of $6.4 million, which includes $5.3 million for Jain's allocated settlement in the DailyGobble Action and $1.1 million for related legal fees. The settlement is aligned with the $6.5 million accrual previously recorded as of June 30, 2026. Cardlytics is actively pursuing insurance reimbursement to recoup portions of the settlement cost.
Cardlytics Issues Q2 2026 Earnings Release and Schedules Investor Conference Call
Cardlytics, Inc. reported its financial results for the second quarter ended June 30, 2026, highlighting continued strategic restructuring and platform contraction. Q2 2026 revenue fell 36.5% year-over-year to $36.88 million, down from $58.04 million in Q2 2025, primarily driven by a 33.8% drop in gross billings ($65.47 million) following the loss and exit of a major U.S. financial institution partner. Monthly Qualified Users (MQUs) fell by 39.0 million year-over-year to 185.4 million. Operating loss for the quarter narrowed to $5.44 million from $9.57 million in Q2 2025 due to aggressive cost-cutting across delivery, sales and marketing, and R&D. Net loss widened to $14.88 million from $9.28 million, impacted by discontinued operations of $6.22 million reflecting legal settlements and indemnification accruals linked to the divested Bridg business. During the period, Cardlytics executed a 1-for-10 reverse stock split on June 5, 2026, and used proceeds from liquidating PAR Technology shares to repay $20.1 million on its credit facility.
WATCHLIST & BRIEFINGS
Receive future signals for Cardlytics & competitors in your briefing
Stay ahead of material M&A deals, leadership changes, account wins, and product rollouts. Polaris7 connects primary filings, company newsrooms, and trade reporting directly into your executive briefing.
- Regular primary-source checks
- Structured Watchlist briefings
- Preserves current context
Market Signal Monitoring
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
Monitor Cardlytics
Follow affected companies in Polaris7 with regular source checks and structured Watchlist briefings.
